Glenmede Trust CO Na Global Blood Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $28,651 - $48,528	-761 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $8,652 - $12,216	164 Added 27.47%	761 $41,000
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $19,102 - $32,073	-392 Reduced 39.64%	597 $37,000
Q4 2019 Feb 12, 2020	BUY	$45.7 - $81.86 $731 - $1,309	16 Added 1.64%	989 $78,000
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $18,140 - $23,164	400 Added 69.81%	973 $47,000
Q2 2019 Aug 13, 2019	BUY	$52.6 - $63.29 $30,139 - $36,265	573 New	573 $30,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.